We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Outperforms Broader Market: What You Need to Know
Read MoreHide Full Article
The most recent trading session ended with Intuitive Surgical, Inc. (ISRG - Free Report) standing at $490.38, reflecting a +2% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.71%. Meanwhile, the Dow gained 1.03%, and the Nasdaq, a tech-heavy index, added 0.6%.
Shares of the company have depreciated by 0.71% over the course of the past month, outperforming the Medical sector's loss of 3.33% and lagging the S&P 500's gain of 6.41%.
The upcoming earnings release of Intuitive Surgical, Inc. will be of great interest to investors. The company's earnings report is expected on October 17, 2024. The company is forecasted to report an EPS of $1.65, showcasing a 13.01% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $2.02 billion, up 15.57% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.67 per share and revenue of $8.1 billion. These totals would mark changes of +16.81% and +13.69%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Intuitive Surgical, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Intuitive Surgical, Inc. is currently sporting a Zacks Rank of #3 (Hold).
From a valuation perspective, Intuitive Surgical, Inc. is currently exchanging hands at a Forward P/E ratio of 72.13. This expresses a premium compared to the average Forward P/E of 26.35 of its industry.
Investors should also note that ISRG has a PEG ratio of 4.15 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.22.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 94, putting it in the top 38% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Outperforms Broader Market: What You Need to Know
The most recent trading session ended with Intuitive Surgical, Inc. (ISRG - Free Report) standing at $490.38, reflecting a +2% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.71%. Meanwhile, the Dow gained 1.03%, and the Nasdaq, a tech-heavy index, added 0.6%.
Shares of the company have depreciated by 0.71% over the course of the past month, outperforming the Medical sector's loss of 3.33% and lagging the S&P 500's gain of 6.41%.
The upcoming earnings release of Intuitive Surgical, Inc. will be of great interest to investors. The company's earnings report is expected on October 17, 2024. The company is forecasted to report an EPS of $1.65, showcasing a 13.01% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $2.02 billion, up 15.57% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.67 per share and revenue of $8.1 billion. These totals would mark changes of +16.81% and +13.69%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Intuitive Surgical, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Intuitive Surgical, Inc. is currently sporting a Zacks Rank of #3 (Hold).
From a valuation perspective, Intuitive Surgical, Inc. is currently exchanging hands at a Forward P/E ratio of 72.13. This expresses a premium compared to the average Forward P/E of 26.35 of its industry.
Investors should also note that ISRG has a PEG ratio of 4.15 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.22.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 94, putting it in the top 38% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.